These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26779614)

  • 21. Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia.
    McGraw KL; Nguyen J; Komrokji RS; Sallman D; Al Ali NH; Padron E; Lancet JE; Moscinski LC; List AF; Zhang L
    Haematologica; 2016 Aug; 101(8):e320-3. PubMed ID: 27081179
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.
    Higgins A; Shah MV
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
    Bally C; Thépot S; Quesnel B; Vey N; Dreyfus F; Fadlallah J; Turlure P; de Botton S; Dartigeas C; de Renzis B; Itzykson R; Fenaux P; Adès L
    Leuk Res; 2013 Jun; 37(6):637-40. PubMed ID: 23499498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy-related myeloid neoplasms: when genetics and environment collide.
    McNerney ME; Godley LA; Le Beau MM
    Nat Rev Cancer; 2017 Aug; 17(9):513-527. PubMed ID: 28835720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT.
    Berger G; Kroeze LI; Koorenhof-Scheele TN; de Graaf AO; Yoshida K; Ueno H; Shiraishi Y; Miyano S; van den Berg E; Schepers H; van der Reijden BA; Ogawa S; Vellenga E; Jansen JH
    Blood; 2018 Apr; 131(16):1846-1857. PubMed ID: 29311096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolving challenge of therapy-related myeloid neoplasms.
    Churpek JE; Larson RA
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):309-17. PubMed ID: 24507808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology and therapy of secondary leukaemias.
    Dann EJ; Rowe JM
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):119-37. PubMed ID: 11355927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy-related acute leukemia.
    Karp JE; Sarkodee-Adoo CB
    Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.
    El Ghannam D; Taalab MM; Ghazy HF; Eneen AF
    Blood Cells Mol Dis; 2014; 53(1-2):61-6. PubMed ID: 24512939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelodysplastic syndrome.
    Hofmann WK; Koeffler HP
    Annu Rev Med; 2005; 56():1-16. PubMed ID: 15660498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in the diagnosis and treatment of secondary acute myeloid leukemia.
    Ossenkoppele G; Montesinos P
    Crit Rev Oncol Hematol; 2019 Jun; 138():6-13. PubMed ID: 31092386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of therapy-related myelodysplasia and acute myeloid leukemia.
    Pedersen-Bjergaard J; Andersen MK; Andersen MT; Christiansen DH
    Leukemia; 2008 Feb; 22(2):240-8. PubMed ID: 18200041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
    Oosterveld M; Suciu S; Muus P; Germing U; Delforge M; Belhabri A; Aul C; Selleslag D; Ferrant A; Marie JP; Amadori S; Jehn U; Mandelli F; Hess U; Hellström-Lindberg E; Cakmak-Wollgast S; Vignetti M; Labar B; Willemze R; de Witte T
    Ann Hematol; 2015 Jan; 94(1):23-34. PubMed ID: 25096636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status and trends in the diagnostics of AML and MDS.
    Shumilov E; Flach J; Kohlmann A; Banz Y; Bonadies N; Fiedler M; Pabst T; Bacher U
    Blood Rev; 2018 Nov; 32(6):508-519. PubMed ID: 29728319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process.
    Zeichner SB; Arellano ML
    Curr Treat Options Oncol; 2015 Aug; 16(8):37. PubMed ID: 26143266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.
    Schwartz JR; Ma J; Kamens J; Westover T; Walsh MP; Brady SW; Robert Michael J; Chen X; Montefiori L; Song G; Wu G; Wu H; Branstetter C; Hiltenbrand R; Walsh MF; Nichols KE; Maciaszek JL; Liu Y; Kumar P; Easton J; Newman S; Rubnitz JE; Mullighan CG; Pounds S; Zhang J; Gruber T; Ma X; Klco JM
    Nat Commun; 2021 Feb; 12(1):985. PubMed ID: 33579957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.